With the pharmaceutical regulatory environment constantly evolving, it is extremely important to always be prepared for an inspection during a clinical trial. As sponsors of clinical trials, pharmaceutical companies are required to ensure GCP guidelines are upheld by implementing inspection readiness. Inspections are a crucial part of clinical trials, and it is extremely important that all companies are ready and properly follow GCP guidelines. Inspections are an ongoing process involving all stakeholders, and the real question is how/what can you do in your organization to reduce the frequency of inspections? By properly preparing for inspections, adopting and understanding all the requirements, and having good documentation and data management, companies will have a better chance of warding off inspections and have successful outcomes their trials.
The conference has grown over the past few years, and 2018 will expand on new topics, case studies and featured panel discussions. Don't miss out on the 7th Clinical Trials Inspection Readiness Summit on August 13-14 in Philadelphia to learn how to maximize inspection readiness and trial successes through better documentation and operational standards.
URLs:
Prices:
Early Bird Pricing - Register by June 29, 2018: USD 1895.0
Standard Pricing - Register after June 29, 2018: USD 2095.0
Onsite Pricing: USD 2195.0
Speakers: Nancy Bitters, Jamie Bridges, Grace Crawford, Elias Dorfman, Kathy Goldstein, Sheila Gwizdak, Tipsuda Kongtong, Carrie Lauer, Ann McCabe, Laura Naranjo, Vaishali Shukla, Johanna Stamates, Katherine Taylor, Steven B. Whittaker
Time: 8:00 am to 5:00 pm
